Gastric Carcinoma Stage IV
2 clinical trials · Condition
◉ Watch Gastric Carcinoma Stage IV
| Record | Firm | Date |
|---|---|---|
| FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III) (NCT04442984) | Blokhin's Russian Cancer Research Center | 2019-11-03 |
| XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) (NCT01748851) | Dong-A University Hospital | 2012-12-01 |
Track Gastric Carcinoma Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.